Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 kinase-like 1 (RPS6KL1) is a protein-coding gene encoding a serine/threonine kinase, part of the AGC family, and is structurally related to S6K1 and S6K2. RPS6KL1 is predicted to participate in protein phosphorylation and chromatin remodeling, and is encoded on human chromosome 14. Although direct functional studies on RPS6KL1 are limited, by analogy with the closely related S6K1 and S6K2, it is likely involved in cell size control, transcription, translation, protein and lipid synthesis, and metabolic regulation. Dysregulation of S6K family members can contribute to cancer, metabolic diseases, and other pathologies, making them notable therapeutic targets. RPS6KL1 is mentioned in the context of certain rare diseases, and could potentially be involved in signaling pathways such as PI3K-AKT-mTOR, interacting with modulators of cell growth and metabolism.
Inhibition of kinase activity to block downstream signaling (mTORC1–S6K axis); Suppression of cell growth, protein synthesis, and metabolic pathway activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 kinase-like 1 (RPS6KL1).